Effect of Probucol and Atorvastatin Treatment on the Self‐Care Ability of Acute Cerebral Infarction Patients: A Randomized Clinical Trial Study
Brain and Behavior · 2025-05 · 15 (5)
DOI: 10.1002/brb3.70552 ↗At a glance
Randomisierte kontrollierte Studie in Brain and Behavior, published online on 2025-05-13. Written by Ning Yu and 6 co-authors. Institution: Department of Neurology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei Province, China. Major MEDLINE topics: Atorvastatin, Probucol, Cerebral Infarction, Self Care. Cited 4 times so far (Crossref); 17 references. The full text is freely available (open access, CC BY 4.0). Funded by: the Traditional Chinese Scientific Research Program of Hebei Province.
Abstract (original language)
Background
To investigate the effect of probucol and atorvastatin on self‐care ability in patients with acute cerebral infarction (ACI).
Methods
Eighty‐one patients with ACI admitted from November 2020 to May 2021 were divided into a combination treatment group (n = 40) and an atorvastatin group (n = 41). The atorvastatin group was given atorvastatin on the basis of conventional treatment, and the combination treatment group was treated with probucol and atorvastatin on the control basis. Self‐care ability and blood lipid levels were assessed at baseline and 6 months after treatment using the Barthel Index (BI) and biochemical tests. The study also included MRI scans to evaluate infarct volume and monitored relevant clinical indicators.
Results
The baseline data of both groups were consistent and comparable. After six months, both groups showed improved self‐care ability, with the combined treatment group exhibiting a more significant improvement (P < 0.05). The combination treatment group also demonstrated a significant reduction in total cholesterol (TCH) and low‐density lipoprotein (LDL) levels compared to the atorvastatin group (P < 0.05). The factors influencing self‐care ability included history of cerebrovascular disease, treatment modality, and LDL levels.
Conclusion
Probucol combined with atorvastatin significantly enhances self‐care ability and improves blood lipid levels in patients with ACI. This combination therapy is safe, feasible, and recommended for clinical application to reduce cognitive decline and improve quality of life in these patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Neurology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei Province, China.
ORCID profiles: Ning Yu, Xiaoxuan Zhang
Funding
- the Traditional Chinese Scientific Research Program of Hebei Province
Cite
APA
Yu, N., Li, Y., Han, X., Sun, Y., Li, Y., Gao, Y., & Zhang, X. (2025). Effect of Probucol and Atorvastatin Treatment on the Self‐Care Ability of Acute Cerebral Infarction Patients: A Randomized Clinical Trial Study. Brain and Behavior, 15(5). https://doi.org/10.1002/brb3.70552
Vancouver
Yu N, Li Y, Han X, Sun Y, Li Y, Gao Y, et al. Effect of Probucol and Atorvastatin Treatment on the Self‐Care Ability of Acute Cerebral Infarction Patients: A Randomized Clinical Trial Study. Brain and Behavior. 2025;15(5). doi:10.1002/brb3.70552
BibTeX
@article{Yu2025,
author = {Yu, Ning and Li, Yajing and Han, Xue and Sun, Yuan and Li, Yun and Gao, Yanjun and Zhang, Xiaoxuan},
title = {Effect of Probucol and Atorvastatin Treatment on the Self‐Care Ability of Acute Cerebral Infarction Patients: A Randomized Clinical Trial Study},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {5},
doi = {10.1002/brb3.70552}
}
EUVIMED